Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga June 18, 2014 at 08:12 AM EDT Endocyte (NASDAQ: ECYT) dipped 19.95% to $6.18 in pre-market trading after the company reported that the company has regained global ... Read More >> Related Stocks: Achison Inc Endocyte Inc Gw Pharma ADR La-Z-Boy Inc